NCT05143281View on ClinicalTrials.gov

The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1

PHASE4CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions

Cataract

Interventions

DRUG

Dexamethasone 0.4 MG [Dextenza]

Ophthalmic Intracanalicular Insert

Trial Locations (2)

67208

Grene Vision Group, Wichita

67212

Grene Vision Group, Wichita

Sponsors

Collaborators (1)

Ocular Therapeutix, Inc.

All Listed Sponsors

collaborator

Ocular Therapeutix, Inc.

INDUSTRY

lead

Grene Vision Group

OTHER